6MCGREGOR A H,MORE L J,SIMPSON K J,et al.Liver death and regeneration in paracetamol toxicity[J].Human & Experimental Toxicology,2003,22:221-227.
7Report of CLOMS Group IV:Benefit Risk Balance for Marketed Drugs:Evaluating Safety Signals.DETAILED EXAMPLE OF A QUANTITA TIVEBENEFIT-RISKEVALUATION:DIPYRONE.CIOMS Geneva,1998:137-149.
9MARKKU K,KATRIINA V,OUTI K.Effects of Nimesulide,Acetylsalicylic Acid,Ibuprofen and Nabumetone on Cyclooxygenase-1-and Cyclooxygenase-2-Mediated Prostanoid Production in Healthy Volunteers ex vivo.Nordic Pharmacological Society[J].Basic & Clinical Pharmacology & Toxicology,2008,104:17-21.
10WHO pharmaceuticals newsletter:Nimesulide-containing products for oral use-marketing suspended in Ireland due to reports of liver failure[EB/OL].2007-05-21.http://www.who.int.
